InSilicoTrials Joins Microsoft for Startups Pegasus Program to Accelerate Digital Transformation in Healthcare
InSilicoTrials, a health tech company developing simulation-based solutions for drug development, today announced its acceptance into the Microsoft for Startups Pegasus Program, an, invitation-only initiative within Microsoft for Startups, designed to accelerate the growth of high-potential startups. This milestone marks a significant step in InSilicoTrials’ mission to modernize healthcare R&D through AI and in silico simulation technologies.
